Research And Markets Research And Markets
0 CHECKOUT

Search for: "Rheumatoid Arthritis Therapeutics Market in Australia"

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs

This report provides in-depth analysis of Rheumatoid Arthritis (RA) market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides...

Published:  May 2015
Price:  From EURUSDGBP

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

The global market for therapies for rheumatoid arthritis reached $19.0 billion in 2014. The market is expected to reach nearly $21.3 billion by 2020 from $19.9 billion in 2015, increasing at a compound...

Published:  July 2016
Price:  From EURUSDGBP

Asia Pacific Autoimmune Disorders Treatment Market - Opportunities and Forecasts, 2014 - 2022

Graves' disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence...

Published:  October 2016
Price:  From EURUSDGBP

Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

GBI Research, the leading business intelligence provider, has released its latest research, “Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch...

Published:  December 2012
Price:  From EURUSDGBP

Autoimmune Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns...

Published:  October 2011
Price:  From EURUSDGBP

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new PharmaPoint report, “PharmaPoint: Rheumatoid Arthritis - Global...

Published:  February 2013
Price:  From EURUSDGBP

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million The report provides separate comprehensive analytics for US, Japan, Europe, Latin America and Rest of...

Published:  February 2010
Price:  From EURUSDGBP

Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

“Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline“ provides insights and analysis into the...

Published:  July 2013
Price:  From EURUSDGBP

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From EURUSDGBP

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From EURUSDGBP

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis

Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From EURUSDGBP

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market...

Published:  November 2012
Price:  From EURUSDGBP

Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis

Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From EURUSDGBP

Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis

Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From EURUSDGBP

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016 Summary ‘Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016’, provides...

Published:  June 2016
Price:  From EURUSDGBP

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - Australia...

Published:  November 2012
Price:  From EURUSDGBP

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis

Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast...

Published:  November 2012
Price:  From EURUSDGBP

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis....

Published:  November 2012
Price:  From EURUSDGBP

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the...

Published:  December 2014
Price:  From EURUSDGBP

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

Published:  December 2014
Price:  From EURUSDGBP
Loading Indicator